CM
FATE icon

Crestline Management’s Fate Therapeutics FATE Stock Holding History

Crestline Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,174
Closed -$96K – 174
2017
Q3 		$96K Buy
+24,174
New +$96K 0.01% 120